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Introduction
Microvascular obstruction (MO) can be evaluated using
contrast-enhanced CMR and is identified as areas of
hypoperfusion in the infarct zone within 3 minutes. How-
ever, a similar phenomenon can be seen on delayed via-
bility images 10 minutes after contrast injection following
acute myocardial infarction (AMI). Due to its shorter
scanning time, the inversion-recovery single-shot true fast
imaging with steady-state precession (ss-IR) allows analy-
sis of any dynamic changes in infarct and "no-reflow"
sizes over time after contrast administration.
Purpose
The aim of this study is to analyze dynamic changes of
MO at different times after contrast administration and
the size of hypoperfusion that best correlates with ven-
tricular remodeling in patients following AMI.
Methods
Subjects were evaluated using CMR within the first week
(n = 60), 3 months (n = 47) and one year (n = 25) after a
ST-segment elevation MI percutaneously revascularized.
Cine CMR was performed to measure left ventricular func-
tion. Additionally, as a gold-standard, segmented inver-
sion-recovery (seg-IR) were acquired 10 min after the
administration of contrast, and ss-IR images were
acquired sequentially at 1, 3, 5, 7, 10, 15, 20, and 25 min
after bolus contrast administration to measure microvas-
cular obstruction. Inversion times were set to properly
null normal myocardium at each time point. All images
were blinded, randomized, and measured for hypo- and
hyper-enhancement volumes.
Results
There was a significant reduction of hypo-enhancement
volumes over time (p < 0.001). Moreover, there was a
71% reduction in the number of patients with hypoen-
hanced areas between the 1st and the 25th min (Figure 1).
The presence of delayed hypoenhancement at each
sequential time point after contrast administration results
in larger infarct size, larger end systolic volume (ESV), and
reduced ejection fraction (EF). The volume of hyper-
enhancement at 15 min and the volume of hypo-
enhancement at 10 and 15 minutes were the best and sig-
nificant univariate predictors for ESV and EF at 1 year fol-
low-up. In the multivariate analysis, when adjusted for
infarct size, the volume of hypoperfusion at 10 min was
the only predictor for ESV (r = 0.7, p = 0.001) and EF (r =
-0.8, p < 0.001) at 1 year follow-up.
Conclusion
Time of imaging after bolus contrast injection is para-
mount to accurately determine the proper "no-reflow"
volume. Infarct size and the volume of microvascular
obstruction can predict adverse ventricular remodeling;
however, the microvascular obstruction volume 10 min
after contrast is the strongest predictor for ESV and EF at
one year follow-up.
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